nodes	percent_of_prediction	percent_of_DWPC	metapath
Bumetanide—PTGS2—pancreatic cancer	0.417	1	CbGaD
Bumetanide—SLC22A7—Fluorouracil—pancreatic cancer	0.0845	0.567	CbGbCtD
Bumetanide—SLC22A7—Docetaxel—pancreatic cancer	0.0646	0.433	CbGbCtD
Bumetanide—CFTR—ventral pancreatic duct—pancreatic cancer	0.0532	0.308	CbGeAlD
Bumetanide—SLC10A1—bile duct—pancreatic cancer	0.0301	0.174	CbGeAlD
Bumetanide—SLC10A1—bile—pancreatic cancer	0.0231	0.133	CbGeAlD
Bumetanide—CFTR—gall bladder—pancreatic cancer	0.00772	0.0446	CbGeAlD
Bumetanide—CA9—gall bladder—pancreatic cancer	0.00668	0.0386	CbGeAlD
Bumetanide—CFTR—islet of Langerhans—pancreatic cancer	0.00506	0.0293	CbGeAlD
Bumetanide—SLC12A2—islet of Langerhans—pancreatic cancer	0.00445	0.0257	CbGeAlD
Bumetanide—CA9—islet of Langerhans—pancreatic cancer	0.00438	0.0253	CbGeAlD
Bumetanide—CFTR—pancreas—pancreatic cancer	0.00356	0.0206	CbGeAlD
Bumetanide—SLC12A2—pancreas—pancreatic cancer	0.00313	0.0181	CbGeAlD
Bumetanide—CFTR—digestive system—pancreatic cancer	0.00304	0.0176	CbGeAlD
Bumetanide—CA7—digestive system—pancreatic cancer	0.00299	0.0173	CbGeAlD
Bumetanide—SLC12A2—digestive system—pancreatic cancer	0.00267	0.0154	CbGeAlD
Bumetanide—CA9—digestive system—pancreatic cancer	0.00263	0.0152	CbGeAlD
Bumetanide—SLC10A1—digestive system—pancreatic cancer	0.00252	0.0146	CbGeAlD
Bumetanide—SLC22A11—digestive system—pancreatic cancer	0.0023	0.0133	CbGeAlD
Bumetanide—SLC22A7—digestive system—pancreatic cancer	0.00225	0.013	CbGeAlD
Bumetanide—CA5B—pancreas—pancreatic cancer	0.00204	0.0118	CbGeAlD
Bumetanide—CA4—islet of Langerhans—pancreatic cancer	0.00201	0.0116	CbGeAlD
Bumetanide—CA12—digestive system—pancreatic cancer	0.00194	0.0112	CbGeAlD
Bumetanide—PTGS2—gall bladder—pancreatic cancer	0.00187	0.0108	CbGeAlD
Bumetanide—Dehydration—Erlotinib—pancreatic cancer	0.00153	0.00763	CcSEcCtD
Bumetanide—Cramp muscle—Tamoxifen—pancreatic cancer	0.0015	0.00747	CcSEcCtD
Bumetanide—Hypokalaemia—Erlotinib—pancreatic cancer	0.0015	0.00747	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Erlotinib—pancreatic cancer	0.00149	0.00739	CcSEcCtD
Bumetanide—Hyponatraemia—Sunitinib—pancreatic cancer	0.00143	0.00714	CcSEcCtD
Bumetanide—Pancreatitis—Tamoxifen—pancreatic cancer	0.00141	0.00703	CcSEcCtD
Bumetanide—Pancreatitis—Erlotinib—pancreatic cancer	0.0014	0.00696	CcSEcCtD
Bumetanide—Abdominal discomfort—Tamoxifen—pancreatic cancer	0.00138	0.00687	CcSEcCtD
Bumetanide—SLCO1A2—digestive system—pancreatic cancer	0.00136	0.00787	CbGeAlD
Bumetanide—Blood creatinine increased—Sunitinib—pancreatic cancer	0.00134	0.00666	CcSEcCtD
Bumetanide—Dehydration—Sunitinib—pancreatic cancer	0.00133	0.00661	CcSEcCtD
Bumetanide—Hypokalaemia—Sunitinib—pancreatic cancer	0.0013	0.00647	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Sunitinib—pancreatic cancer	0.00129	0.0064	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Tamoxifen—pancreatic cancer	0.00127	0.00634	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Erlotinib—pancreatic cancer	0.00126	0.00627	CcSEcCtD
Bumetanide—Renal failure—Erlotinib—pancreatic cancer	0.00125	0.00622	CcSEcCtD
Bumetanide—Sweating—Tamoxifen—pancreatic cancer	0.00123	0.00613	CcSEcCtD
Bumetanide—Serum creatinine increased—Epirubicin—pancreatic cancer	0.00123	0.00611	CcSEcCtD
Bumetanide—PTGS2—islet of Langerhans—pancreatic cancer	0.00123	0.0071	CbGeAlD
Bumetanide—Pancreatitis—Sunitinib—pancreatic cancer	0.00121	0.00602	CcSEcCtD
Bumetanide—CA4—digestive system—pancreatic cancer	0.0012	0.00696	CbGeAlD
Bumetanide—Abdominal discomfort—Sunitinib—pancreatic cancer	0.00118	0.00589	CcSEcCtD
Bumetanide—Hyponatraemia—Irinotecan—pancreatic cancer	0.00118	0.00588	CcSEcCtD
Bumetanide—Hearing impaired—Docetaxel—pancreatic cancer	0.00118	0.00586	CcSEcCtD
Bumetanide—Serum creatinine increased—Doxorubicin—pancreatic cancer	0.00114	0.00566	CcSEcCtD
Bumetanide—Hepatocellular injury—Docetaxel—pancreatic cancer	0.00112	0.00557	CcSEcCtD
Bumetanide—Hyperglycaemia—Sunitinib—pancreatic cancer	0.00111	0.00554	CcSEcCtD
Bumetanide—Blood creatinine increased—Irinotecan—pancreatic cancer	0.0011	0.00548	CcSEcCtD
Bumetanide—Hyperventilation—Epirubicin—pancreatic cancer	0.0011	0.00546	CcSEcCtD
Bumetanide—Dehydration—Irinotecan—pancreatic cancer	0.00109	0.00544	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Sunitinib—pancreatic cancer	0.00109	0.00543	CcSEcCtD
Bumetanide—Erythema multiforme—Tamoxifen—pancreatic cancer	0.00109	0.00543	CcSEcCtD
Bumetanide—Renal failure—Sunitinib—pancreatic cancer	0.00108	0.00538	CcSEcCtD
Bumetanide—Erythema multiforme—Erlotinib—pancreatic cancer	0.00108	0.00537	CcSEcCtD
Bumetanide—Blood creatinine increased—Gemcitabine—pancreatic cancer	0.00107	0.00534	CcSEcCtD
Bumetanide—Hypokalaemia—Irinotecan—pancreatic cancer	0.00107	0.00533	CcSEcCtD
Bumetanide—Cramp muscle—Irinotecan—pancreatic cancer	0.00106	0.00527	CcSEcCtD
Bumetanide—Hypokalaemia—Gemcitabine—pancreatic cancer	0.00104	0.00519	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Gemcitabine—pancreatic cancer	0.00103	0.00513	CcSEcCtD
Bumetanide—Hyperventilation—Doxorubicin—pancreatic cancer	0.00102	0.00506	CcSEcCtD
Bumetanide—Pancreatitis—Irinotecan—pancreatic cancer	0.000997	0.00496	CcSEcCtD
Bumetanide—Muscle spasms—Tamoxifen—pancreatic cancer	0.000965	0.0048	CcSEcCtD
Bumetanide—Erythema multiforme—Sunitinib—pancreatic cancer	0.000934	0.00465	CcSEcCtD
Bumetanide—Glycosuria—Epirubicin—pancreatic cancer	0.000933	0.00464	CcSEcCtD
Bumetanide—Blood disorder—Epirubicin—pancreatic cancer	0.000905	0.0045	CcSEcCtD
Bumetanide—Leukopenia—Tamoxifen—pancreatic cancer	0.000899	0.00447	CcSEcCtD
Bumetanide—Liver injury—Epirubicin—pancreatic cancer	0.000898	0.00447	CcSEcCtD
Bumetanide—Hyperglycaemia—Gemcitabine—pancreatic cancer	0.000893	0.00445	CcSEcCtD
Bumetanide—Renal failure—Irinotecan—pancreatic cancer	0.000891	0.00443	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Gemcitabine—pancreatic cancer	0.000875	0.00436	CcSEcCtD
Bumetanide—Sweating—Irinotecan—pancreatic cancer	0.000869	0.00432	CcSEcCtD
Bumetanide—Renal failure—Gemcitabine—pancreatic cancer	0.000868	0.00432	CcSEcCtD
Bumetanide—PTGS2—pancreas—pancreatic cancer	0.000863	0.00499	CbGeAlD
Bumetanide—Glycosuria—Doxorubicin—pancreatic cancer	0.000863	0.00429	CcSEcCtD
Bumetanide—Chest pain—Tamoxifen—pancreatic cancer	0.000855	0.00425	CcSEcCtD
Bumetanide—Arthralgia—Tamoxifen—pancreatic cancer	0.000855	0.00425	CcSEcCtD
Bumetanide—Sweating—Gemcitabine—pancreatic cancer	0.000846	0.00421	CcSEcCtD
Bumetanide—Chest pain—Erlotinib—pancreatic cancer	0.000846	0.00421	CcSEcCtD
Bumetanide—Arthralgia—Erlotinib—pancreatic cancer	0.000846	0.00421	CcSEcCtD
Bumetanide—Blood disorder—Doxorubicin—pancreatic cancer	0.000837	0.00417	CcSEcCtD
Bumetanide—Dry mouth—Tamoxifen—pancreatic cancer	0.000836	0.00416	CcSEcCtD
Bumetanide—Liver injury—Doxorubicin—pancreatic cancer	0.000831	0.00413	CcSEcCtD
Bumetanide—Muscle spasms—Sunitinib—pancreatic cancer	0.000827	0.00411	CcSEcCtD
Bumetanide—Hyponatraemia—Docetaxel—pancreatic cancer	0.000816	0.00406	CcSEcCtD
Bumetanide—Hyperuricaemia—Epirubicin—pancreatic cancer	0.000814	0.00405	CcSEcCtD
Bumetanide—Thrombocytopenia—Tamoxifen—pancreatic cancer	0.000802	0.00399	CcSEcCtD
Bumetanide—Thrombocytopenia—Erlotinib—pancreatic cancer	0.000794	0.00395	CcSEcCtD
Bumetanide—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.000792	0.00394	CcSEcCtD
Bumetanide—Leukopenia—Sunitinib—pancreatic cancer	0.00077	0.00383	CcSEcCtD
Bumetanide—Blood uric acid increased—Epirubicin—pancreatic cancer	0.000769	0.00383	CcSEcCtD
Bumetanide—Musculoskeletal pain—Epirubicin—pancreatic cancer	0.000765	0.00381	CcSEcCtD
Bumetanide—Dehydration—Docetaxel—pancreatic cancer	0.000756	0.00376	CcSEcCtD
Bumetanide—Hepatocellular injury—Epirubicin—pancreatic cancer	0.000756	0.00376	CcSEcCtD
Bumetanide—Hyperuricaemia—Doxorubicin—pancreatic cancer	0.000754	0.00375	CcSEcCtD
Bumetanide—Erythema multiforme—Gemcitabine—pancreatic cancer	0.000749	0.00373	CcSEcCtD
Bumetanide—PTGS2—digestive system—pancreatic cancer	0.000737	0.00426	CbGeAlD
Bumetanide—Toxic epidermal necrolysis—Docetaxel—pancreatic cancer	0.000732	0.00364	CcSEcCtD
Bumetanide—Cramp muscle—Docetaxel—pancreatic cancer	0.000732	0.00364	CcSEcCtD
Bumetanide—Arthralgia—Sunitinib—pancreatic cancer	0.000732	0.00364	CcSEcCtD
Bumetanide—Chest pain—Sunitinib—pancreatic cancer	0.000732	0.00364	CcSEcCtD
Bumetanide—Dry mouth—Sunitinib—pancreatic cancer	0.000716	0.00356	CcSEcCtD
Bumetanide—Blood uric acid increased—Doxorubicin—pancreatic cancer	0.000712	0.00354	CcSEcCtD
Bumetanide—Musculoskeletal pain—Doxorubicin—pancreatic cancer	0.000708	0.00352	CcSEcCtD
Bumetanide—Fatigue—Tamoxifen—pancreatic cancer	0.000706	0.00352	CcSEcCtD
Bumetanide—Hepatocellular injury—Doxorubicin—pancreatic cancer	0.000699	0.00348	CcSEcCtD
Bumetanide—Fatigue—Erlotinib—pancreatic cancer	0.000699	0.00348	CcSEcCtD
Bumetanide—Thrombocytopenia—Sunitinib—pancreatic cancer	0.000687	0.00342	CcSEcCtD
Bumetanide—Muscle spasms—Irinotecan—pancreatic cancer	0.000681	0.00339	CcSEcCtD
Bumetanide—Gastrointestinal pain—Tamoxifen—pancreatic cancer	0.00067	0.00333	CcSEcCtD
Bumetanide—Gastrointestinal pain—Erlotinib—pancreatic cancer	0.000663	0.0033	CcSEcCtD
Bumetanide—Urticaria—Tamoxifen—pancreatic cancer	0.000651	0.00324	CcSEcCtD
Bumetanide—Abdominal pain—Tamoxifen—pancreatic cancer	0.000648	0.00322	CcSEcCtD
Bumetanide—Abdominal pain—Erlotinib—pancreatic cancer	0.000641	0.00319	CcSEcCtD
Bumetanide—Vertigo—Irinotecan—pancreatic cancer	0.000636	0.00317	CcSEcCtD
Bumetanide—Leukopenia—Irinotecan—pancreatic cancer	0.000634	0.00316	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Docetaxel—pancreatic cancer	0.000621	0.00309	CcSEcCtD
Bumetanide—Leukopenia—Gemcitabine—pancreatic cancer	0.000618	0.00307	CcSEcCtD
Bumetanide—Renal failure—Docetaxel—pancreatic cancer	0.000616	0.00307	CcSEcCtD
Bumetanide—Leukopenia—Fluorouracil—pancreatic cancer	0.000607	0.00302	CcSEcCtD
Bumetanide—Fatigue—Sunitinib—pancreatic cancer	0.000605	0.00301	CcSEcCtD
Bumetanide—Asthenia—Tamoxifen—pancreatic cancer	0.000588	0.00293	CcSEcCtD
Bumetanide—Arthralgia—Gemcitabine—pancreatic cancer	0.000587	0.00292	CcSEcCtD
Bumetanide—Chest pain—Gemcitabine—pancreatic cancer	0.000587	0.00292	CcSEcCtD
Bumetanide—Asthenia—Erlotinib—pancreatic cancer	0.000582	0.00289	CcSEcCtD
Bumetanide—Pruritus—Tamoxifen—pancreatic cancer	0.00058	0.00289	CcSEcCtD
Bumetanide—Chest pain—Fluorouracil—pancreatic cancer	0.000578	0.00287	CcSEcCtD
Bumetanide—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.000574	0.00286	CcSEcCtD
Bumetanide—Pruritus—Erlotinib—pancreatic cancer	0.000574	0.00285	CcSEcCtD
Bumetanide—Thrombocytopenia—Irinotecan—pancreatic cancer	0.000566	0.00282	CcSEcCtD
Bumetanide—Diarrhoea—Tamoxifen—pancreatic cancer	0.000561	0.00279	CcSEcCtD
Bumetanide—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000559	0.00278	CcSEcCtD
Bumetanide—Abdominal pain—Sunitinib—pancreatic cancer	0.000555	0.00276	CcSEcCtD
Bumetanide—Diarrhoea—Erlotinib—pancreatic cancer	0.000555	0.00276	CcSEcCtD
Bumetanide—Thrombocytopenia—Gemcitabine—pancreatic cancer	0.000551	0.00274	CcSEcCtD
Bumetanide—Hyponatraemia—Epirubicin—pancreatic cancer	0.000551	0.00274	CcSEcCtD
Bumetanide—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000544	0.00271	CcSEcCtD
Bumetanide—Thrombocytopenia—Fluorouracil—pancreatic cancer	0.000542	0.0027	CcSEcCtD
Bumetanide—Dizziness—Tamoxifen—pancreatic cancer	0.000542	0.0027	CcSEcCtD
Bumetanide—Hypotension—Irinotecan—pancreatic cancer	0.00054	0.00269	CcSEcCtD
Bumetanide—Dizziness—Erlotinib—pancreatic cancer	0.000536	0.00267	CcSEcCtD
Bumetanide—Erythema multiforme—Docetaxel—pancreatic cancer	0.000532	0.00265	CcSEcCtD
Bumetanide—Hypotension—Gemcitabine—pancreatic cancer	0.000526	0.00262	CcSEcCtD
Bumetanide—Vomiting—Tamoxifen—pancreatic cancer	0.000521	0.00259	CcSEcCtD
Bumetanide—Hypotension—Fluorouracil—pancreatic cancer	0.000517	0.00257	CcSEcCtD
Bumetanide—Rash—Tamoxifen—pancreatic cancer	0.000517	0.00257	CcSEcCtD
Bumetanide—Dermatitis—Tamoxifen—pancreatic cancer	0.000516	0.00257	CcSEcCtD
Bumetanide—Vomiting—Erlotinib—pancreatic cancer	0.000515	0.00257	CcSEcCtD
Bumetanide—Blood creatinine increased—Epirubicin—pancreatic cancer	0.000514	0.00256	CcSEcCtD
Bumetanide—Headache—Tamoxifen—pancreatic cancer	0.000513	0.00255	CcSEcCtD
Bumetanide—Rash—Erlotinib—pancreatic cancer	0.000511	0.00254	CcSEcCtD
Bumetanide—Dermatitis—Erlotinib—pancreatic cancer	0.000511	0.00254	CcSEcCtD
Bumetanide—Dehydration—Epirubicin—pancreatic cancer	0.00051	0.00254	CcSEcCtD
Bumetanide—Hyponatraemia—Doxorubicin—pancreatic cancer	0.000509	0.00254	CcSEcCtD
Bumetanide—Headache—Erlotinib—pancreatic cancer	0.000508	0.00253	CcSEcCtD
Bumetanide—Asthenia—Sunitinib—pancreatic cancer	0.000504	0.00251	CcSEcCtD
Bumetanide—Hypokalaemia—Epirubicin—pancreatic cancer	0.000499	0.00248	CcSEcCtD
Bumetanide—Fatigue—Irinotecan—pancreatic cancer	0.000498	0.00248	CcSEcCtD
Bumetanide—Pruritus—Sunitinib—pancreatic cancer	0.000497	0.00247	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	0.000494	0.00246	CcSEcCtD
Bumetanide—Nausea—Tamoxifen—pancreatic cancer	0.000487	0.00242	CcSEcCtD
Bumetanide—Fatigue—Gemcitabine—pancreatic cancer	0.000486	0.00242	CcSEcCtD
Bumetanide—Nausea—Erlotinib—pancreatic cancer	0.000482	0.0024	CcSEcCtD
Bumetanide—Diarrhoea—Sunitinib—pancreatic cancer	0.00048	0.00239	CcSEcCtD
Bumetanide—Blood creatinine increased—Doxorubicin—pancreatic cancer	0.000475	0.00237	CcSEcCtD
Bumetanide—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000473	0.00235	CcSEcCtD
Bumetanide—Dehydration—Doxorubicin—pancreatic cancer	0.000472	0.00235	CcSEcCtD
Bumetanide—Muscle spasms—Docetaxel—pancreatic cancer	0.000471	0.00234	CcSEcCtD
Bumetanide—Pancreatitis—Epirubicin—pancreatic cancer	0.000465	0.00231	CcSEcCtD
Bumetanide—Dizziness—Sunitinib—pancreatic cancer	0.000464	0.00231	CcSEcCtD
Bumetanide—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000462	0.0023	CcSEcCtD
Bumetanide—Abdominal pain—Irinotecan—pancreatic cancer	0.000457	0.00227	CcSEcCtD
Bumetanide—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	0.000457	0.00227	CcSEcCtD
Bumetanide—Vomiting—Sunitinib—pancreatic cancer	0.000446	0.00222	CcSEcCtD
Bumetanide—Rash—Sunitinib—pancreatic cancer	0.000443	0.0022	CcSEcCtD
Bumetanide—Dermatitis—Sunitinib—pancreatic cancer	0.000442	0.0022	CcSEcCtD
Bumetanide—Urticaria—Fluorouracil—pancreatic cancer	0.00044	0.00219	CcSEcCtD
Bumetanide—Headache—Sunitinib—pancreatic cancer	0.00044	0.00219	CcSEcCtD
Bumetanide—Leukopenia—Docetaxel—pancreatic cancer	0.000438	0.00218	CcSEcCtD
Bumetanide—Pancreatitis—Doxorubicin—pancreatic cancer	0.00043	0.00214	CcSEcCtD
Bumetanide—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000428	0.00213	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	0.000419	0.00209	CcSEcCtD
Bumetanide—Arthralgia—Docetaxel—pancreatic cancer	0.000417	0.00207	CcSEcCtD
Bumetanide—Chest pain—Docetaxel—pancreatic cancer	0.000417	0.00207	CcSEcCtD
Bumetanide—Nausea—Sunitinib—pancreatic cancer	0.000417	0.00207	CcSEcCtD
Bumetanide—Renal failure—Epirubicin—pancreatic cancer	0.000415	0.00207	CcSEcCtD
Bumetanide—Asthenia—Irinotecan—pancreatic cancer	0.000415	0.00206	CcSEcCtD
Bumetanide—Dry mouth—Docetaxel—pancreatic cancer	0.000408	0.00203	CcSEcCtD
Bumetanide—Sweating—Epirubicin—pancreatic cancer	0.000405	0.00202	CcSEcCtD
Bumetanide—Asthenia—Gemcitabine—pancreatic cancer	0.000404	0.00201	CcSEcCtD
Bumetanide—Pruritus—Gemcitabine—pancreatic cancer	0.000398	0.00198	CcSEcCtD
Bumetanide—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000396	0.00197	CcSEcCtD
Bumetanide—Diarrhoea—Irinotecan—pancreatic cancer	0.000396	0.00197	CcSEcCtD
Bumetanide—Pruritus—Fluorouracil—pancreatic cancer	0.000392	0.00195	CcSEcCtD
Bumetanide—Thrombocytopenia—Docetaxel—pancreatic cancer	0.000391	0.00195	CcSEcCtD
Bumetanide—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	0.000388	0.00193	CcSEcCtD
Bumetanide—Diarrhoea—Gemcitabine—pancreatic cancer	0.000385	0.00192	CcSEcCtD
Bumetanide—Renal failure—Doxorubicin—pancreatic cancer	0.000384	0.00191	CcSEcCtD
Bumetanide—Dizziness—Irinotecan—pancreatic cancer	0.000382	0.0019	CcSEcCtD
Bumetanide—Diarrhoea—Fluorouracil—pancreatic cancer	0.000379	0.00189	CcSEcCtD
Bumetanide—Sweating—Doxorubicin—pancreatic cancer	0.000375	0.00187	CcSEcCtD
Bumetanide—Hypotension—Docetaxel—pancreatic cancer	0.000373	0.00186	CcSEcCtD
Bumetanide—Vomiting—Irinotecan—pancreatic cancer	0.000368	0.00183	CcSEcCtD
Bumetanide—Dizziness—Fluorouracil—pancreatic cancer	0.000366	0.00182	CcSEcCtD
Bumetanide—Rash—Irinotecan—pancreatic cancer	0.000365	0.00181	CcSEcCtD
Bumetanide—Dermatitis—Irinotecan—pancreatic cancer	0.000364	0.00181	CcSEcCtD
Bumetanide—Headache—Irinotecan—pancreatic cancer	0.000362	0.0018	CcSEcCtD
Bumetanide—Erythema multiforme—Epirubicin—pancreatic cancer	0.000359	0.00179	CcSEcCtD
Bumetanide—Vomiting—Gemcitabine—pancreatic cancer	0.000358	0.00178	CcSEcCtD
Bumetanide—Rash—Gemcitabine—pancreatic cancer	0.000355	0.00177	CcSEcCtD
Bumetanide—Dermatitis—Gemcitabine—pancreatic cancer	0.000355	0.00177	CcSEcCtD
Bumetanide—Headache—Gemcitabine—pancreatic cancer	0.000353	0.00176	CcSEcCtD
Bumetanide—Vomiting—Fluorouracil—pancreatic cancer	0.000352	0.00175	CcSEcCtD
Bumetanide—Rash—Fluorouracil—pancreatic cancer	0.000349	0.00174	CcSEcCtD
Bumetanide—Dermatitis—Fluorouracil—pancreatic cancer	0.000349	0.00174	CcSEcCtD
Bumetanide—Headache—Fluorouracil—pancreatic cancer	0.000347	0.00173	CcSEcCtD
Bumetanide—Fatigue—Docetaxel—pancreatic cancer	0.000345	0.00171	CcSEcCtD
Bumetanide—Nausea—Irinotecan—pancreatic cancer	0.000343	0.00171	CcSEcCtD
Bumetanide—Nausea—Gemcitabine—pancreatic cancer	0.000334	0.00166	CcSEcCtD
Bumetanide—Erythema multiforme—Doxorubicin—pancreatic cancer	0.000332	0.00165	CcSEcCtD
Bumetanide—Nausea—Fluorouracil—pancreatic cancer	0.000329	0.00164	CcSEcCtD
Bumetanide—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000327	0.00163	CcSEcCtD
Bumetanide—Muscle spasms—Epirubicin—pancreatic cancer	0.000318	0.00158	CcSEcCtD
Bumetanide—Abdominal pain—Docetaxel—pancreatic cancer	0.000316	0.00157	CcSEcCtD
Bumetanide—Vertigo—Epirubicin—pancreatic cancer	0.000297	0.00148	CcSEcCtD
Bumetanide—Leukopenia—Epirubicin—pancreatic cancer	0.000296	0.00147	CcSEcCtD
Bumetanide—Muscle spasms—Doxorubicin—pancreatic cancer	0.000294	0.00146	CcSEcCtD
Bumetanide—Asthenia—Docetaxel—pancreatic cancer	0.000287	0.00143	CcSEcCtD
Bumetanide—Pruritus—Docetaxel—pancreatic cancer	0.000283	0.00141	CcSEcCtD
Bumetanide—Arthralgia—Epirubicin—pancreatic cancer	0.000281	0.0014	CcSEcCtD
Bumetanide—Chest pain—Epirubicin—pancreatic cancer	0.000281	0.0014	CcSEcCtD
Bumetanide—Dry mouth—Epirubicin—pancreatic cancer	0.000275	0.00137	CcSEcCtD
Bumetanide—Vertigo—Doxorubicin—pancreatic cancer	0.000275	0.00137	CcSEcCtD
Bumetanide—Leukopenia—Doxorubicin—pancreatic cancer	0.000274	0.00136	CcSEcCtD
Bumetanide—Diarrhoea—Docetaxel—pancreatic cancer	0.000273	0.00136	CcSEcCtD
Bumetanide—Dizziness—Docetaxel—pancreatic cancer	0.000264	0.00132	CcSEcCtD
Bumetanide—Thrombocytopenia—Epirubicin—pancreatic cancer	0.000264	0.00131	CcSEcCtD
Bumetanide—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000261	0.0013	CcSEcCtD
Bumetanide—Chest pain—Doxorubicin—pancreatic cancer	0.00026	0.00129	CcSEcCtD
Bumetanide—Arthralgia—Doxorubicin—pancreatic cancer	0.00026	0.00129	CcSEcCtD
Bumetanide—Dry mouth—Doxorubicin—pancreatic cancer	0.000254	0.00127	CcSEcCtD
Bumetanide—Vomiting—Docetaxel—pancreatic cancer	0.000254	0.00126	CcSEcCtD
Bumetanide—Rash—Docetaxel—pancreatic cancer	0.000252	0.00125	CcSEcCtD
Bumetanide—Hypotension—Epirubicin—pancreatic cancer	0.000252	0.00125	CcSEcCtD
Bumetanide—Dermatitis—Docetaxel—pancreatic cancer	0.000252	0.00125	CcSEcCtD
Bumetanide—Headache—Docetaxel—pancreatic cancer	0.00025	0.00125	CcSEcCtD
Bumetanide—Thrombocytopenia—Doxorubicin—pancreatic cancer	0.000244	0.00122	CcSEcCtD
Bumetanide—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000241	0.0012	CcSEcCtD
Bumetanide—Nausea—Docetaxel—pancreatic cancer	0.000237	0.00118	CcSEcCtD
Bumetanide—Hypotension—Doxorubicin—pancreatic cancer	0.000233	0.00116	CcSEcCtD
Bumetanide—Fatigue—Epirubicin—pancreatic cancer	0.000232	0.00116	CcSEcCtD
Bumetanide—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00022	0.0011	CcSEcCtD
Bumetanide—Fatigue—Doxorubicin—pancreatic cancer	0.000215	0.00107	CcSEcCtD
Bumetanide—Urticaria—Epirubicin—pancreatic cancer	0.000214	0.00107	CcSEcCtD
Bumetanide—Abdominal pain—Epirubicin—pancreatic cancer	0.000213	0.00106	CcSEcCtD
Bumetanide—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000204	0.00102	CcSEcCtD
Bumetanide—Urticaria—Doxorubicin—pancreatic cancer	0.000198	0.000986	CcSEcCtD
Bumetanide—Abdominal pain—Doxorubicin—pancreatic cancer	0.000197	0.000981	CcSEcCtD
Bumetanide—Asthenia—Epirubicin—pancreatic cancer	0.000193	0.000962	CcSEcCtD
Bumetanide—Pruritus—Epirubicin—pancreatic cancer	0.000191	0.000949	CcSEcCtD
Bumetanide—Diarrhoea—Epirubicin—pancreatic cancer	0.000184	0.000918	CcSEcCtD
Bumetanide—Asthenia—Doxorubicin—pancreatic cancer	0.000179	0.000891	CcSEcCtD
Bumetanide—Dizziness—Epirubicin—pancreatic cancer	0.000178	0.000887	CcSEcCtD
Bumetanide—Pruritus—Doxorubicin—pancreatic cancer	0.000176	0.000878	CcSEcCtD
Bumetanide—Vomiting—Epirubicin—pancreatic cancer	0.000171	0.000853	CcSEcCtD
Bumetanide—Diarrhoea—Doxorubicin—pancreatic cancer	0.000171	0.000849	CcSEcCtD
Bumetanide—Rash—Epirubicin—pancreatic cancer	0.00017	0.000846	CcSEcCtD
Bumetanide—Dermatitis—Epirubicin—pancreatic cancer	0.00017	0.000845	CcSEcCtD
Bumetanide—Headache—Epirubicin—pancreatic cancer	0.000169	0.00084	CcSEcCtD
Bumetanide—Dizziness—Doxorubicin—pancreatic cancer	0.000165	0.000821	CcSEcCtD
Bumetanide—Nausea—Epirubicin—pancreatic cancer	0.00016	0.000797	CcSEcCtD
Bumetanide—Vomiting—Doxorubicin—pancreatic cancer	0.000159	0.000789	CcSEcCtD
Bumetanide—Rash—Doxorubicin—pancreatic cancer	0.000157	0.000783	CcSEcCtD
Bumetanide—Dermatitis—Doxorubicin—pancreatic cancer	0.000157	0.000782	CcSEcCtD
Bumetanide—Headache—Doxorubicin—pancreatic cancer	0.000156	0.000778	CcSEcCtD
Bumetanide—Nausea—Doxorubicin—pancreatic cancer	0.000148	0.000737	CcSEcCtD
Bumetanide—CA14—Metabolism—GCG—pancreatic cancer	7.09e-05	0.00118	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—DPYD—pancreatic cancer	7.09e-05	0.00118	CbGpPWpGaD
Bumetanide—SLCO1A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	7.07e-05	0.00118	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—CXCL8—pancreatic cancer	6.99e-05	0.00116	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—GCG—pancreatic cancer	6.91e-05	0.00115	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TYMP—pancreatic cancer	6.89e-05	0.00115	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GLP1R—pancreatic cancer	6.87e-05	0.00115	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	6.79e-05	0.00113	CbGpPWpGaD
Bumetanide—CA4—Metabolism—DPYD—pancreatic cancer	6.76e-05	0.00113	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—SLC2A2—pancreatic cancer	6.73e-05	0.00112	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—CD44—pancreatic cancer	6.73e-05	0.00112	CbGpPWpGaD
Bumetanide—CA7—Metabolism—CD44—pancreatic cancer	6.73e-05	0.00112	CbGpPWpGaD
Bumetanide—CA14—Metabolism—STK11—pancreatic cancer	6.67e-05	0.00111	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.66e-05	0.00111	CbGpPWpGaD
Bumetanide—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.64e-05	0.00111	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	6.57e-05	0.0011	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—STK11—pancreatic cancer	6.5e-05	0.00108	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	6.45e-05	0.00108	CbGpPWpGaD
Bumetanide—CA7—Metabolism—GCG—pancreatic cancer	6.45e-05	0.00108	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—GCG—pancreatic cancer	6.45e-05	0.00108	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—RB1—pancreatic cancer	6.43e-05	0.00107	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	6.43e-05	0.00107	CbGpPWpGaD
Bumetanide—CA4—Metabolism—SLC2A2—pancreatic cancer	6.42e-05	0.00107	CbGpPWpGaD
Bumetanide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—pancreatic cancer	6.39e-05	0.00107	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—CCND1—pancreatic cancer	6.27e-05	0.00105	CbGpPWpGaD
Bumetanide—CA12—Metabolism—CD44—pancreatic cancer	6.23e-05	0.00104	CbGpPWpGaD
Bumetanide—CA7—Metabolism—STK11—pancreatic cancer	6.06e-05	0.00101	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—STK11—pancreatic cancer	6.06e-05	0.00101	CbGpPWpGaD
Bumetanide—CA12—Metabolism—GCG—pancreatic cancer	5.98e-05	0.000996	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.85e-05	0.000976	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PRSS1—pancreatic cancer	5.8e-05	0.000968	CbGpPWpGaD
Bumetanide—CA14—Metabolism—TYMS—pancreatic cancer	5.73e-05	0.000956	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—VEGFA—pancreatic cancer	5.67e-05	0.000946	CbGpPWpGaD
Bumetanide—CA12—Metabolism—STK11—pancreatic cancer	5.62e-05	0.000937	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—STAT3—pancreatic cancer	5.62e-05	0.000937	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—TYMS—pancreatic cancer	5.59e-05	0.000932	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GLP1R—pancreatic cancer	5.56e-05	0.000926	CbGpPWpGaD
Bumetanide—CA9—Metabolism—DPYD—pancreatic cancer	5.47e-05	0.000911	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—NRAS—pancreatic cancer	5.4e-05	0.0009	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—TYMS—pancreatic cancer	5.22e-05	0.00087	CbGpPWpGaD
Bumetanide—CA7—Metabolism—TYMS—pancreatic cancer	5.22e-05	0.00087	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—CD44—pancreatic cancer	5.21e-05	0.000869	CbGpPWpGaD
Bumetanide—CA9—Metabolism—SLC2A2—pancreatic cancer	5.19e-05	0.000865	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CXCL8—pancreatic cancer	5.13e-05	0.000855	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	5.1e-05	0.000851	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	5.05e-05	0.000843	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—ARG2—pancreatic cancer	5.03e-05	0.000839	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—MYC—pancreatic cancer	5.03e-05	0.000839	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—GCG—pancreatic cancer	4.99e-05	0.000833	CbGpPWpGaD
Bumetanide—CA4—Metabolism—CD44—pancreatic cancer	4.97e-05	0.000829	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CASP3—pancreatic cancer	4.91e-05	0.000818	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.89e-05	0.000816	CbGpPWpGaD
Bumetanide—CA12—Metabolism—TYMS—pancreatic cancer	4.83e-05	0.000806	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—CCND1—pancreatic cancer	4.78e-05	0.000797	CbGpPWpGaD
Bumetanide—CA4—Metabolism—GCG—pancreatic cancer	4.77e-05	0.000795	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—STK11—pancreatic cancer	4.7e-05	0.000783	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.68e-05	0.000781	CbGpPWpGaD
Bumetanide—CA14—Metabolism—APOE—pancreatic cancer	4.66e-05	0.000778	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—KRAS—pancreatic cancer	4.65e-05	0.000775	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MMP9—pancreatic cancer	4.64e-05	0.000773	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—APOE—pancreatic cancer	4.54e-05	0.000758	CbGpPWpGaD
Bumetanide—PTGS2—Selenium Micronutrient Network—TNF—pancreatic cancer	4.51e-05	0.000753	CbGpPWpGaD
Bumetanide—CA4—Metabolism—STK11—pancreatic cancer	4.48e-05	0.000747	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.41e-05	0.000735	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TYMP—pancreatic cancer	4.4e-05	0.000733	CbGpPWpGaD
Bumetanide—CA9—Cellular responses to stress—TP53—pancreatic cancer	4.29e-05	0.000715	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—APOE—pancreatic cancer	4.24e-05	0.000707	CbGpPWpGaD
Bumetanide—CA7—Metabolism—APOE—pancreatic cancer	4.24e-05	0.000707	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CG—pancreatic cancer	4.21e-05	0.000702	CbGpPWpGaD
Bumetanide—PTGS2—Disease—ZNRF3—pancreatic cancer	4.19e-05	0.000698	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PRSS1—pancreatic cancer	4.19e-05	0.000698	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CG—pancreatic cancer	4.1e-05	0.000684	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PPARG—pancreatic cancer	4.06e-05	0.000677	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—TYMS—pancreatic cancer	4.04e-05	0.000674	CbGpPWpGaD
Bumetanide—CA9—Metabolism—CD44—pancreatic cancer	4.02e-05	0.00067	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PPARG—pancreatic cancer	3.96e-05	0.00066	CbGpPWpGaD
Bumetanide—PTGS2—C-MYB transcription factor network—HRAS—pancreatic cancer	3.95e-05	0.000659	CbGpPWpGaD
Bumetanide—CA12—Metabolism—APOE—pancreatic cancer	3.93e-05	0.000655	CbGpPWpGaD
Bumetanide—CA4—Metabolism—TYMS—pancreatic cancer	3.85e-05	0.000643	CbGpPWpGaD
Bumetanide—CA9—Metabolism—GCG—pancreatic cancer	3.85e-05	0.000642	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—MYC—pancreatic cancer	3.83e-05	0.000639	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CG—pancreatic cancer	3.83e-05	0.000638	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CG—pancreatic cancer	3.83e-05	0.000638	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TGFB1—pancreatic cancer	3.82e-05	0.000637	CbGpPWpGaD
Bumetanide—PTGS2—Disease—DTX1—pancreatic cancer	3.79e-05	0.000631	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—EGFR—pancreatic cancer	3.75e-05	0.000625	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CD—pancreatic cancer	3.7e-05	0.000617	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PPARG—pancreatic cancer	3.7e-05	0.000616	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PPARG—pancreatic cancer	3.7e-05	0.000616	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	3.63e-05	0.000605	CbGpPWpGaD
Bumetanide—CA9—Metabolism—STK11—pancreatic cancer	3.62e-05	0.000604	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CD—pancreatic cancer	3.61e-05	0.000601	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TNF—pancreatic cancer	3.57e-05	0.000595	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CG—pancreatic cancer	3.55e-05	0.000591	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	3.55e-05	0.000591	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PRSS1—pancreatic cancer	3.51e-05	0.000584	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—DPYD—pancreatic cancer	3.49e-05	0.000582	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PPARG—pancreatic cancer	3.42e-05	0.000571	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CD—pancreatic cancer	3.37e-05	0.000561	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CD—pancreatic cancer	3.37e-05	0.000561	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.34e-05	0.000557	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	3.31e-05	0.000552	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—APOE—pancreatic cancer	3.29e-05	0.000548	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	3.28e-05	0.000546	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.25e-05	0.000542	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CB—pancreatic cancer	3.22e-05	0.000538	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.22e-05	0.000537	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTGS2—pancreatic cancer	3.2e-05	0.000533	CbGpPWpGaD
Bumetanide—PTGS2—Disease—DTX4—pancreatic cancer	3.17e-05	0.000529	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	3.16e-05	0.000527	CbGpPWpGaD
Bumetanide—PTGS2—Spinal Cord Injury—TP53—pancreatic cancer	3.15e-05	0.000525	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CB—pancreatic cancer	3.14e-05	0.000524	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.14e-05	0.000523	CbGpPWpGaD
Bumetanide—CA4—Metabolism—APOE—pancreatic cancer	3.13e-05	0.000523	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CD—pancreatic cancer	3.12e-05	0.00052	CbGpPWpGaD
Bumetanide—CA9—Metabolism—TYMS—pancreatic cancer	3.11e-05	0.000519	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTGS2—pancreatic cancer	3.11e-05	0.000519	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.11e-05	0.000519	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PPP2R5B—pancreatic cancer	3.09e-05	0.000514	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—ARG2—pancreatic cancer	3.04e-05	0.000507	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HEY2—pancreatic cancer	2.97e-05	0.000495	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CG—pancreatic cancer	2.97e-05	0.000494	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CB—pancreatic cancer	2.93e-05	0.000489	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CB—pancreatic cancer	2.93e-05	0.000489	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.91e-05	0.000485	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTGS2—pancreatic cancer	2.91e-05	0.000485	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTGS2—pancreatic cancer	2.91e-05	0.000485	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	2.88e-05	0.00048	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PPARG—pancreatic cancer	2.86e-05	0.000477	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.83e-05	0.000472	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CG—pancreatic cancer	2.83e-05	0.000472	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PTEN—pancreatic cancer	2.79e-05	0.000465	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HEY1—pancreatic cancer	2.75e-05	0.000459	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PPARG—pancreatic cancer	2.73e-05	0.000455	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CB—pancreatic cancer	2.72e-05	0.000453	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PTEN—pancreatic cancer	2.72e-05	0.000453	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTGS2—pancreatic cancer	2.69e-05	0.000449	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TYMP—pancreatic cancer	2.66e-05	0.000443	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.61e-05	0.000435	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CD—pancreatic cancer	2.61e-05	0.000435	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.6e-05	0.000434	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—CD44—pancreatic cancer	2.56e-05	0.000427	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.55e-05	0.000425	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PTEN—pancreatic cancer	2.54e-05	0.000423	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PTEN—pancreatic cancer	2.54e-05	0.000423	CbGpPWpGaD
Bumetanide—CA9—Metabolism—APOE—pancreatic cancer	2.53e-05	0.000422	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	2.51e-05	0.000419	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	2.49e-05	0.000415	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CD—pancreatic cancer	2.49e-05	0.000415	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—GCG—pancreatic cancer	2.46e-05	0.00041	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JAG2—pancreatic cancer	2.44e-05	0.000407	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.43e-05	0.000405	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.41e-05	0.000402	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MEN1—pancreatic cancer	2.4e-05	0.000401	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SLC2A2—pancreatic cancer	2.39e-05	0.000398	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PTEN—pancreatic cancer	2.35e-05	0.000392	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—STK11—pancreatic cancer	2.31e-05	0.000385	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SHH—pancreatic cancer	2.29e-05	0.000382	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CG—pancreatic cancer	2.29e-05	0.000381	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CB—pancreatic cancer	2.27e-05	0.000379	CbGpPWpGaD
Bumetanide—PTGS2—Disease—IAPP—pancreatic cancer	2.26e-05	0.000378	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTGS2—pancreatic cancer	2.25e-05	0.000375	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.21e-05	0.000369	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PPARG—pancreatic cancer	2.21e-05	0.000368	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	2.19e-05	0.000365	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HSPA1B—pancreatic cancer	2.17e-05	0.000362	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	2.17e-05	0.000362	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CB—pancreatic cancer	2.17e-05	0.000361	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTGS2—pancreatic cancer	2.15e-05	0.000358	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GLP1R—pancreatic cancer	2.14e-05	0.000357	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.14e-05	0.000357	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—DPYD—pancreatic cancer	2.11e-05	0.000351	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CD—pancreatic cancer	2.01e-05	0.000335	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—SLC2A2—pancreatic cancer	2e-05	0.000333	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—TYMS—pancreatic cancer	1.99e-05	0.000331	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.98e-05	0.00033	CbGpPWpGaD
Bumetanide—CA14—Metabolism—PIK3CA—pancreatic cancer	1.97e-05	0.000328	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PTEN—pancreatic cancer	1.96e-05	0.000327	CbGpPWpGaD
Bumetanide—PTGS2—Disease—JAG1—pancreatic cancer	1.95e-05	0.000324	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—PIK3CA—pancreatic cancer	1.92e-05	0.000319	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.91e-05	0.000318	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PTEN—pancreatic cancer	1.87e-05	0.000312	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CD44—pancreatic cancer	1.85e-05	0.000308	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HSPA1A—pancreatic cancer	1.84e-05	0.000306	CbGpPWpGaD
Bumetanide—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.81e-05	0.000301	CbGpPWpGaD
Bumetanide—CA7—Metabolism—PIK3CA—pancreatic cancer	1.79e-05	0.000298	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—PIK3CA—pancreatic cancer	1.79e-05	0.000298	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CB—pancreatic cancer	1.75e-05	0.000292	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.74e-05	0.00029	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTGS2—pancreatic cancer	1.74e-05	0.000289	CbGpPWpGaD
Bumetanide—CA12—Metabolism—PIK3CA—pancreatic cancer	1.66e-05	0.000276	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—APOE—pancreatic cancer	1.62e-05	0.00027	CbGpPWpGaD
Bumetanide—CA14—Metabolism—AKT1—pancreatic cancer	1.61e-05	0.000268	CbGpPWpGaD
Bumetanide—CA5A—Metabolism—AKT1—pancreatic cancer	1.56e-05	0.000261	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—CD44—pancreatic cancer	1.55e-05	0.000258	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	1.53e-05	0.000255	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	1.52e-05	0.000253	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PTEN—pancreatic cancer	1.51e-05	0.000252	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—GCG—pancreatic cancer	1.48e-05	0.000247	CbGpPWpGaD
Bumetanide—CA7—Metabolism—AKT1—pancreatic cancer	1.46e-05	0.000244	CbGpPWpGaD
Bumetanide—CA5B—Metabolism—AKT1—pancreatic cancer	1.46e-05	0.000244	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SMAD4—pancreatic cancer	1.46e-05	0.000243	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	1.46e-05	0.000243	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HES1—pancreatic cancer	1.42e-05	0.000238	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PPARG—pancreatic cancer	1.41e-05	0.000235	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—STK11—pancreatic cancer	1.4e-05	0.000233	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—PIK3CA—pancreatic cancer	1.39e-05	0.000231	CbGpPWpGaD
Bumetanide—CA12—Metabolism—AKT1—pancreatic cancer	1.35e-05	0.000226	CbGpPWpGaD
Bumetanide—CA4—Metabolism—PIK3CA—pancreatic cancer	1.32e-05	0.00022	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	1.31e-05	0.000218	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	1.28e-05	0.000214	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TERT—pancreatic cancer	1.25e-05	0.000208	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—TYMS—pancreatic cancer	1.2e-05	0.0002	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HIF1A—pancreatic cancer	1.19e-05	0.000199	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TSC2—pancreatic cancer	1.19e-05	0.000199	CbGpPWpGaD
Bumetanide—PTGS2—Disease—APOE—pancreatic cancer	1.17e-05	0.000194	CbGpPWpGaD
Bumetanide—SLC10A1—Metabolism—AKT1—pancreatic cancer	1.13e-05	0.000189	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	1.12e-05	0.000186	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	1.11e-05	0.000185	CbGpPWpGaD
Bumetanide—CA4—Metabolism—AKT1—pancreatic cancer	1.08e-05	0.00018	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NOTCH1—pancreatic cancer	1.08e-05	0.000179	CbGpPWpGaD
Bumetanide—CA9—Metabolism—PIK3CA—pancreatic cancer	1.07e-05	0.000178	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGF—pancreatic cancer	1.04e-05	0.000173	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—APOE—pancreatic cancer	9.76e-06	0.000163	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PTEN—pancreatic cancer	9.66e-06	0.000161	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CD—pancreatic cancer	9.25e-06	0.000154	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	9.24e-06	0.000154	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CG—pancreatic cancer	8.81e-06	0.000147	CbGpPWpGaD
Bumetanide—CA9—Metabolism—AKT1—pancreatic cancer	8.72e-06	0.000145	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PPARG—pancreatic cancer	8.5e-06	0.000142	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CB—pancreatic cancer	8.06e-06	0.000134	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CD—pancreatic cancer	7.75e-06	0.000129	CbGpPWpGaD
Bumetanide—PTGS2—Disease—CTNNB1—pancreatic cancer	7.15e-06	0.000119	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PTEN—pancreatic cancer	6.97e-06	0.000116	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	6.81e-06	0.000114	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CB—pancreatic cancer	6.75e-06	0.000113	CbGpPWpGaD
Bumetanide—PTGS2—Disease—SRC—pancreatic cancer	6.46e-06	0.000108	CbGpPWpGaD
Bumetanide—PTGS2—Disease—STAT3—pancreatic cancer	6.23e-06	0.000104	CbGpPWpGaD
Bumetanide—PTGS2—Disease—NRAS—pancreatic cancer	6.21e-06	0.000104	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PTEN—pancreatic cancer	5.83e-06	9.73e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—MYC—pancreatic cancer	5.79e-06	9.65e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—TGFB1—pancreatic cancer	5.77e-06	9.63e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—EGFR—pancreatic cancer	5.66e-06	9.44e-05	CbGpPWpGaD
Bumetanide—SLCO1A2—Metabolism—AKT1—pancreatic cancer	5.57e-06	9.28e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—KRAS—pancreatic cancer	5.35e-06	8.92e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—PIK3CA—pancreatic cancer	4.91e-06	8.19e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—HRAS—pancreatic cancer	4.55e-06	7.58e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—PIK3CA—pancreatic cancer	4.12e-06	6.86e-05	CbGpPWpGaD
Bumetanide—PTGS2—Disease—AKT1—pancreatic cancer	4.01e-06	6.69e-05	CbGpPWpGaD
Bumetanide—PTGS2—Metabolism—AKT1—pancreatic cancer	3.36e-06	5.61e-05	CbGpPWpGaD
